Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-230327
Filing Date
2019-08-27
Accepted
2019-08-27 10:58:05
Documents
6
Period of Report
2019-10-03
Effectiveness Date
2019-08-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A d780962ddef14a.htm DEF 14A 395129
2 GRAPHIC g780962g03m87.jpg GRAPHIC 2207
3 GRAPHIC g780962g10r12.jpg GRAPHIC 24294
4 GRAPHIC g780962g68d40.jpg GRAPHIC 7348
5 GRAPHIC g780962g82l95.jpg GRAPHIC 13033
6 GRAPHIC g780962g87e29.jpg GRAPHIC 500
  Complete submission text file 0001193125-19-230327.txt   461923
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: DEF 14A | Act: 34 | File No.: 000-17988 | Film No.: 191055104
SIC: 2835 In Vitro & In Vivo Diagnostic Substances